Merck & Co Inc (MRK)
131.95
+0.20
(+0.15%)
USD |
NYSE |
Mar 28, 16:00
131.99
+0.04
(+0.03%)
Pre-Market: 20:00
Merck Accounts Payable (Quarterly): 3.922B for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 3.922B |
September 30, 2023 | 3.509B |
June 30, 2023 | 3.442B |
March 31, 2023 | 3.68B |
December 31, 2022 | 4.264B |
September 30, 2022 | 3.371B |
June 30, 2022 | 3.482B |
March 31, 2022 | 3.715B |
December 31, 2021 | 4.609B |
September 30, 2021 | 3.366B |
June 30, 2021 | 3.897B |
March 31, 2021 | 4.034B |
December 31, 2020 | 4.327B |
September 30, 2020 | 3.744B |
June 30, 2020 | 3.448B |
March 31, 2020 | 3.572B |
December 31, 2019 | 3.738B |
September 30, 2019 | 3.198B |
June 30, 2019 | 3.142B |
March 31, 2019 | 3.018B |
December 31, 2018 | 3.318B |
September 30, 2018 | 3.091B |
June 30, 2018 | 3.024B |
March 31, 2018 | 3.162B |
December 31, 2017 | 3.102B |
Date | Value |
---|---|
September 30, 2017 | 2.62B |
June 30, 2017 | 2.934B |
March 31, 2017 | 2.484B |
December 31, 2016 | 2.807B |
September 30, 2016 | 2.481B |
June 30, 2016 | 2.514B |
March 31, 2016 | 2.241B |
December 31, 2015 | 2.533B |
September 30, 2015 | 2.023B |
June 30, 2015 | 2.335B |
March 31, 2015 | 2.091B |
December 31, 2014 | 2.625B |
September 30, 2014 | 2.279B |
June 30, 2014 | 2.326B |
March 31, 2014 | 2.434B |
December 31, 2013 | 2.274B |
September 30, 2013 | 2.469B |
June 30, 2013 | 2.253B |
March 31, 2013 | 2.084B |
December 31, 2012 | 1.753B |
September 30, 2012 | 1.804B |
June 30, 2012 | 1.674B |
March 31, 2012 | 2.358B |
December 31, 2011 | 2.023B |
September 30, 2011 | 2.282B |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
3.018B
Minimum
Mar 2019
4.609B
Maximum
Dec 2021
3.674B
Average
3.626B
Median
Accounts Payable (Quarterly) Benchmarks
Amgen Inc | 1.59B |
Gilead Sciences Inc | 550.00M |
Johnson & Johnson | 9.632B |
Harpoon Therapeutics Inc (DELISTED) | 3.435M |
Moderna Inc | 520.00M |